Giovanni Zanderigo , Filippo Bracco , Quirico Semeraro, Bianca Maria Colosimo
{"title":"In-situ Printability Maps (IPM): A new approach for in-situ printability assessment with application to extrusion-based bioprinting","authors":"Giovanni Zanderigo , Filippo Bracco , Quirico Semeraro, Bianca Maria Colosimo","doi":"10.1016/j.bprint.2023.e00320","DOIUrl":null,"url":null,"abstract":"<div><p>3D Bioprinting is an emerging field with many highly valuable applications. The most common and versatile technology is extrusion-based bioprinting, which requires extensive experimental campaigns to achieve appropriate quality of the bioprinted constructs when new bioinks or complex geometrical constructs need to be considered. This paper presents a new approach to easily guide operators and scientists to evaluate the probability of successful bioprinting in a defined window of the process parameters, starting from a small experimental campaign and relying on in-situ quality data. The proposed method consists of defining printability maps based on a probabilistic approach. These maps assess the printing outcome considering a specified acceptable deviation from the nominal geometry, which is predefined by the end-user depending on the application at hand. Even if shown with reference to extrusion-based bioprinting, the proposed method can be used with any other bioprinting process and any quality index, including categorical assessment classification. Eventually, the paper shows how the map can be combined with different quality criteria (e.g., productivity, cell viability) to define the appropriate setting, depending on the application at hand. Furthermore, the map provides a practical tool for rapid material printability assessment and robust process optimization. It offers an enhanced visual representation of the process domain, acceptable region boundaries, and their resilience to variation and uncertainties. Eventually, in-situ printability maps represent a further leap for the advancement of bioprinting toward the digital transformation, aiming at increasing the controllability and scalability of the bioprinting process.</p></div>","PeriodicalId":37770,"journal":{"name":"Bioprinting","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405886623000635/pdfft?md5=5bcffbc444b8b4176701ef2611963f0d&pid=1-s2.0-S2405886623000635-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioprinting","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405886623000635","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Computer Science","Score":null,"Total":0}
引用次数: 0
Abstract
3D Bioprinting is an emerging field with many highly valuable applications. The most common and versatile technology is extrusion-based bioprinting, which requires extensive experimental campaigns to achieve appropriate quality of the bioprinted constructs when new bioinks or complex geometrical constructs need to be considered. This paper presents a new approach to easily guide operators and scientists to evaluate the probability of successful bioprinting in a defined window of the process parameters, starting from a small experimental campaign and relying on in-situ quality data. The proposed method consists of defining printability maps based on a probabilistic approach. These maps assess the printing outcome considering a specified acceptable deviation from the nominal geometry, which is predefined by the end-user depending on the application at hand. Even if shown with reference to extrusion-based bioprinting, the proposed method can be used with any other bioprinting process and any quality index, including categorical assessment classification. Eventually, the paper shows how the map can be combined with different quality criteria (e.g., productivity, cell viability) to define the appropriate setting, depending on the application at hand. Furthermore, the map provides a practical tool for rapid material printability assessment and robust process optimization. It offers an enhanced visual representation of the process domain, acceptable region boundaries, and their resilience to variation and uncertainties. Eventually, in-situ printability maps represent a further leap for the advancement of bioprinting toward the digital transformation, aiming at increasing the controllability and scalability of the bioprinting process.
期刊介绍:
Bioprinting is a broad-spectrum, multidisciplinary journal that covers all aspects of 3D fabrication technology involving biological tissues, organs and cells for medical and biotechnology applications. Topics covered include nanomaterials, biomaterials, scaffolds, 3D printing technology, imaging and CAD/CAM software and hardware, post-printing bioreactor maturation, cell and biological factor patterning, biofabrication, tissue engineering and other applications of 3D bioprinting technology. Bioprinting publishes research reports describing novel results with high clinical significance in all areas of 3D bioprinting research. Bioprinting issues contain a wide variety of review and analysis articles covering topics relevant to 3D bioprinting ranging from basic biological, material and technical advances to pre-clinical and clinical applications of 3D bioprinting.